Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytesJosé Alberto Navarro‐García, Gema Ruiz‐Hurtado, María Fernández‐Velasco et al.|Nephrology Dialysis Transplantation|2018Cited by 52
Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line HemodiafiltrationJosé Alberto Navarro‐García, Gema Ruiz‐Hurtado, Judith Abarca‐Zabalía et al.|Nutrients|2019Cited by 29
The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23José Alberto Navarro‐García, María Fernández‐Velasco, Laura Martín‐Nunes et al.|BMC Medicine|2022Cited by 21
Variations in Circulating Active MMP-9 Levels during Renal Replacement TherapyElena Rodríguez‐Sánchez, Gema Ruiz‐Hurtado, Judith Abarca‐Zabalía et al.|Biomolecules|2020Cited by 10
P3494Fibroblast growth factor (FGF)-23 induces ventricular arrhytmogenesis through Ca2+ handling dysregulationJosé Alberto Navarro‐García, Gema Ruiz‐Hurtado, J Solís et al.|European Heart Journal|2017Cited by 0